MiRus Receives Breakthrough Device Designation for Spine Implant

Atlanta – July 31, 2024 – MiRus has received Breakthrough Device Designation from the FDA for the EUROPA® Posterior Cervical System, based on it’s proprietary rhenium alloys, for treatment of the cervical and upper thoracic spine. The EUROPA® PCF system is built around a 2.9 mm MoRe rod which is much smaller than current commercial … MiRus Receives Breakthrough Device Designation for Spine Implant Read More » The post MiRus Receives Breakthrough Device Designation for Spine Implant appeared first on MiRus .